Advanced Reconstructive Surgery Alliance Launches Platform
ARSA is partnering with leading reconstructive and cosmetic surgeons as a “strategic partner” that offers members greater economies of scale and a competitive advantage.
ARSA is partnering with leading reconstructive and cosmetic surgeons as a “strategic partner” that offers members greater economies of scale and a competitive advantage.
If approved, upadacitinib will be the first systemic medication available for patients with vitiligo, according to the company.